The U.S. Food and Drug Administration (FDA) has officially stated it will not endorse leucovorin, a drug previously suggested as a potential treatment for autism spectrum disorder (ASD). White House Briefing Raised Hopes Just last fall, in a White House briefing, FDA Commissioner Dr....




